The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcoma

10.18632/oncotarget.2648 ◽

2014 ◽

Vol 5 (24) ◽

pp. 12753-12768 ◽

Author(s):

Emmy D.G. Fleuren ◽

Melissa H.S. Hillebrandt-Roeffen ◽

Uta E. Flucke ◽

D. Maroeska W.M. te Loo ◽

Otto C. Boerman ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Ewing Sarcoma ◽

Kinase Inhibitor ◽

Vitro Activity ◽

In Vitro Activity ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text

CM082, a novel VEGF receptor tyrosine kinase inhibitor, can inhibit angiogenesis in vitro and in vivo

Microvascular Research ◽

10.1016/j.mvr.2021.104146 ◽

2021 ◽

Vol 136 ◽

pp. 104146

Author(s):

Handong Dan ◽

Xinlan Lei ◽

Xin Huang ◽

Ning Ma ◽

Yiqiao Xing ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Vegf Receptor ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text

The in vitro activity of the tyrosine kinase inhibitor STI571 in BCR–ABL positive chronic myeloid leukaemia cells: synergistic interactions with anti-leukaemic agents

British Journal of Cancer ◽

10.1038/sj.bjc.6600288 ◽

2002 ◽

Vol 86 (9) ◽

pp. 1472-1478 ◽

Author(s):

W M Liu ◽

L A Stimson ◽

S P Joel

Keyword(s):

Chronic Myeloid Leukaemia ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Myeloid Leukaemia ◽

Kinase Inhibitor ◽

Vitro Activity ◽

In Vitro Activity ◽

Synergistic Interactions

Download Full-text

Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo

Gynecologic Oncology ◽

10.1016/j.ygyno.2015.01.142 ◽

2015 ◽

Vol 137 ◽

pp. 61

Author(s):

C.L. Schwab ◽

D.P. English ◽

J.D. Black ◽

S. Lopez ◽

S. Bellone ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Erbb Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Erbb Receptor Tyrosine Kinase

Download Full-text

A Receptor Tyrosine Kinase Inhibitor, Dovitinib (TKI-258), Enhances BMP-2-Induced Osteoblast Differentiation In Vitro

Molecules and Cells ◽

10.14348/molcells.2016.2300 ◽

2016 ◽

Vol 39 (5) ◽

pp. 389-394 ◽

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Osteoblast Differentiation ◽

Kinase Inhibitor ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text

Dacomitinib (PF-00299804), a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor, demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro

Tumor Biology ◽

10.1007/s13277-015-3218-4 ◽

2015 ◽

Vol 36 (7) ◽

pp. 5505-5513 ◽

Author(s):

Liancheng Zhu ◽

Salvatore Lopez ◽

Stefania Bellone ◽

Jonathan Black ◽

Emiliano Cocco ◽

...

Keyword(s):

Endometrial Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Second Generation ◽

Kinase Inhibitor ◽

Erbb Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Erbb Receptor Tyrosine Kinase

Download Full-text

Interaction Potential of the Multitargeted Receptor Tyrosine Kinase Inhibitor Dovitinib with Drug Transporters and Drug Metabolising Enzymes Assessed in Vitro

Pharmaceutics ◽

10.3390/pharmaceutics6040632 ◽

2014 ◽

Vol 6 (4) ◽

pp. 632-650 ◽

Author(s):

Johanna Weiss ◽

Dirk Theile ◽

Zdenek Dvorak ◽

Walter Haefeli

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Interaction Potential ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Drug Transporters ◽

Receptor Tyrosine Kinase Inhibitor ◽

Drug Metabolising Enzymes

Download Full-text

70 POSTER In vitro activity of the multi targeted receptor tyrosine kinase inhibitor sunitinib against multiple myeloma cell lines is not predictive of in vivo xenograft response

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(08)72002-0 ◽

2008 ◽

Vol 6 (12) ◽

pp. 25

Author(s):

M. Batey ◽

J.L.R. Brito ◽

H. Maitland ◽

H. Leung ◽

A. Hall ◽

...

Keyword(s):

Multiple Myeloma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Myeloma Cell ◽

In Vitro Activity ◽

Multiple Myeloma Cell

Download Full-text

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

10.32388/jfobd7 ◽

2020 ◽

Author(s):

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Epidermal Growth

Download Full-text

Delayed Therapy with Receptor Tyrosine Kinase Inhibitor Nintedanib Diminished Chronic Rejection in a Murine Lung Transplant Model

10.1055/s-0041-1725623 ◽

2021 ◽

Author(s):

J. Mauer ◽

A. Kuckhahn ◽

J. Distler ◽

B. Spriewald ◽

M. Ramsperger-Gleixner ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Chronic Rejection ◽

Lung Transplant ◽

Kinase Inhibitor ◽

Murine Lung ◽

Receptor Tyrosine Kinase Inhibitor ◽

Transplant Model

Download Full-text

Everolimus zur Behandlung des metastasierten Nierenzellkarzinoms nach Versagen der ersten VEGFr-TKI(Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor)-Therapie: Ergebnisse einer Interimsanalyse einer nichtinterventionellen Studie

Karger Kompass Onkologie ◽

10.1159/000356898 ◽

2014 ◽

Vol 1 (1) ◽

pp. 28-29

Keyword(s):

Vascular Endothelial Growth Factor ◽

Growth Factor ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Vascular Endothelial ◽

Receptor Tyrosine Kinase Inhibitor ◽

Endothelial Growth Factor

Download Full-text